On December 6^th, 2012, the 14^th International Symposium on Hypertension & Related Diseases organized by China Hypertension League and National Cardiovascular Disease Center was successfully held in Kingkey Dameisha Great Hotel, Shenzhen City. Angy (China) Medical Limited actively attended this grand symposium.

In combination of the research progress and the latest hypertension prevention and treatment guideline at home and abroad, this symposium explored various aspects of comprehensive management scheme for the prevention and treatment of hypertension and related diseases by studying hypertension and the interdisciplinary subjects related to hypertension, such as atrial fibrillation, diabetes mellitus, kidney disease and stroke, from basic research, clinical practice to community management.  The committee invited distinguished experts worldwide to share with all the participants the recent development and innovation of hypertension researches.

As the most common cardiovascular disease and a major public health problem in the world, hypertension has been listed as one of the top ten threats to human health. As a professional supplier of medical device and pertinent service, Angy pays great attention to the new development and innovation in cardiovascular field. Last year, Angy brought in the world’s leading device--AtCor SphygmoCor Cardiovascular Manager System, which can non-invasively measure central blood pressure, arterial stiffness, cardiac workload (Aix) and HRV. This device is widely used in the fields of cardiology, nephropathy and diabetes for early prevention, early measurement, early diagnosis and early treatment of cardiovascular disease. With the 1^st market share worldwide, AtCor SphygmoCor Cardiovascular Manager System is used by many domestic well-known hospitals and research institutes for detection and research. Angy also took the symposium as an opportunity to learn and communicate with  well-known experts as well as to answer questions from the users.